drugset / Trial / NCT00497536
Pharmacokinetics of IAsp Following CSII in Patients With T1DM
RandomizedCrossoverOpen-labelTreatment
Summary
The primary objective of the study is to compare SSPIAsp during CSII giving one bolus per hour compared with multiple boluses per hour. The secondary objective is to compare SSPIAsp during continuous subcutaneous insulin infusion (CSII) versus continuous intravenous insulin infusion (CIII).
Timeline
- Start
- 2007-07
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Insulin Aspart (IAsp) | Unknown | 100 iu | Subcutaneous |